Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Strohalm

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|March 15, 1990
The pharmacokinetics of polymer-bound adriamycinL W Seymour, K Ulbrich, J Strohalm, et al.
Journal of Drug Targeting|January 1, 1993
Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanomaK B O'Hare, R Duncan, J Strohalm, et al.
Journal of Drug Targeting|January 1, 1996
Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinomaM V Pimm, A C Perkins, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 22, 1998
Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigensM Jelínková, J Strohalm, D Plocová, et al.
Japanese Journal of Cancer Research : Gann|May 26, 1998
Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissuesY Noguchi, J Wu, R Duncan, et al.
Current Medicinal Chemistry|October 3, 2013
HPMA copolymer-bound doxorubicin induces immunogenic tumor cell deathM Sirova, M Kabesova, L Kovar, et al.
British Journal of Cancer|February 1, 1988
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemiaR Duncan, P Kopecková, J Strohalm, et al.
Journal of Chromatography|April 11, 1986
Bioaffinity therapy with antibodies and drugs bound to soluble synthetic polymersB Ríhová, J Kopecek, P Kopecková-Rejmanová, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierL W Seymour, Y Miyamoto, H Maeda, et al.
British Journal of Cancer|June 1, 1991
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 miceL W Seymour, K Ulbrich, S R Wedge, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|March 15, 1990
The pharmacokinetics of polymer-bound adriamycinL W Seymour, K Ulbrich, J Strohalm, et al.
Journal of Drug Targeting|January 1, 1993
Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanomaK B O'Hare, R Duncan, J Strohalm, et al.
Journal of Drug Targeting|January 1, 1996
Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinomaM V Pimm, A C Perkins, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 22, 1998
Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigensM Jelínková, J Strohalm, D Plocová, et al.
Japanese Journal of Cancer Research : Gann|May 26, 1998
Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissuesY Noguchi, J Wu, R Duncan, et al.
Current Medicinal Chemistry|October 3, 2013
HPMA copolymer-bound doxorubicin induces immunogenic tumor cell deathM Sirova, M Kabesova, L Kovar, et al.
British Journal of Cancer|February 1, 1988
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemiaR Duncan, P Kopecková, J Strohalm, et al.
Journal of Chromatography|April 11, 1986
Bioaffinity therapy with antibodies and drugs bound to soluble synthetic polymersB Ríhová, J Kopecek, P Kopecková-Rejmanová, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierL W Seymour, Y Miyamoto, H Maeda, et al.
British Journal of Cancer|June 1, 1991
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 miceL W Seymour, K Ulbrich, S R Wedge, et al.
Pageof 4